Intravenous prostacyclin combined with inhaled nitric oxide therapy for an infant with alveolar capillary dysplasia.
Kinugasa
Hideyo
H
Department of Pediatrics, Institute of Clinical Medicine, Tennodai, Tsukuba, Japan. hideyo@xa2.so-net.ne.jp
Horigome
Hitoshi
H
Sugiura
Masatoshi
M
Saito
Takashi
T
Iijima
Tatsuo
T
Matsui
Akira
A
D000280:Administration, Inhalation; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D011464:Epoprostenol / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D008297:Male; D009569:Nitric Oxide / Q000008:administration & dosage / Q000627:therapeutic use*; D010547:Persistent Fetal Circulation Syndrome / Q000628:therapy*; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D014665:Vasodilator Agents; D009569:Nitric Oxide; D011464:Epoprostenol